Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Keywords

Refractory (planetary science)MedicineInternal medicineOncologyLymphomaBiology

Affiliated Institutions

Related Publications

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster , Michael Bishop , Constantine S. Tam +21 more

In this international study of CAR T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma in adults, high rates of durable responses were produced with the use o...

2018 New England Journal of Medicine 3775 citations

BCL-6 EXPRESSION IN REACTIVE LYMPHOID TISSUE AND IN B-CELL NON-HODGKIN'S LYMPHOMAS

Stefania Pittaluga , Torik Ayoubi , Iwona Wlodarska +6 more

Chromosomal abnormalities involving 3q27 have recently been associated with diffuse large B-cell lymphomas and, less frequently, with follicular lymphomas. Molecular studies hav...

1996 The Journal of Pathology 47 citations

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

Abstract The recognition of several new types of non-Hodgkin's lymphoma (NHL) in recent years has led to proposals for changing lymphoma classifications, including a new proposa...

1997 Blood 2450 citations

Cancer immunotherapy using checkpoint blockade

Antoni Ribas , Jedd D. Wolchok

The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...

2018 Science 6236 citations

A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells.

Leonardo Flenghi , B. H. Ye , Marco Fizzotti +7 more

The BCL-6 gene is frequently involved in translocations occurring at the 3q27 locus and is rearranged in approximately 30% of diffuse large cell lymphomas and in a small fractio...

1995 PubMed 97 citations

Publication Info

Year: 2020
Type: article
Volume: 396
Issue: 10254
Pages: 839-852
Citations: 2118
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2118

OpenAlex

Cite This

APA Style

                            
                                
                                    Jeremy S. Abramson, 
                                
                                    M. Lia Palomba, 
                                
                                    Leo I. Gordon
                                
                                et al.
                            
                            (2020). 
                            Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. 
                            The Lancet
                            , 396
                            (10254)
                            , 839-852.
                            https://doi.org/10.1016/s0140-6736(20)31366-0
                        

Identifiers

DOI: 10.1016/s0140-6736(20)31366-0